After treatment with [Bi-213]anti-CD20, caspase-3 activation and hence PARP cleavage were observed in radio-/chemosensitive as well as in radio-/chemoresistant CD20-positive NHL cells. The gene discussed is CASP3; the disease is non-Hodgkin lymphoma.